STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #735 by analyst upside · 2026-08-14
OABI
OmniAb, Inc.
Healthcare · Market Cap $499M · P/E 0x
ANALYST PRICE TARGET
+113.8%
implied upside to consensus target
Current Price $3.43
Consensus Target $7.33
Bull Target $11.0
Bear Target $3.0
Analysts Covering 6
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
6
Hold
0
Sell
0
52-Week Low $1.3
52-Week High $3.63
YTD Return +82.4%
FUNDAMENTALS
Market Cap $499M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-0.36
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $38M
Profit Margin -115.1%
52-WEEK RANGE
52-Week Low $1.3
52-Week High $3.63
Current Price $3.43
Bear Target $3.0
Bull Target $11.0
● Now $3.43 ● Target $7.33
TRADING DATA
Avg Volume 653K
YTD Return +82.4%
Analyst Count 6
Consensus Buy
Upside to Target +113.8%
Last Updated 2026-08-14

ANALYST SUMMARY

OmniAb, Inc. (OABI) is currently trading at $3.43 with a Wall Street consensus price target of $7.33, implying potential upside of 113.8% over the next 12 months. 6 analysts currently cover OABI, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $11.0, while the most cautious has a target of $3.0.

OABI operates in the Healthcare sector with a market capitalisation of $499M. The stock is up 82.4% year-to-date and is currently trading near the upper end of its 52-week range of $1.3 – $3.63.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for OABI, with each firm's 90-day track record across all stocks we track. See full firm rankings →

RBC Capital - Reiterated
Outperform → Outperform 2025-08-07 Building track record
Benchmark reit
Buy → Buy 2025-05-12 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2025-03-27 Building track record
Benchmark - Reiterated
Buy → Buy 2025-03-20 Building track record
HC Wainwright & Co. reit
Buy → Buy 2025-03-19 31% win rate (48 calls)
Benchmark reit
Buy → Buy 2024-11-14 Building track record
HC Wainwright & Co. reit
Buy → Buy 2024-11-14 31% win rate (48 calls)
Benchmark reit
Buy → Buy 2024-08-19 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
42
out of 100
Coverage depth
15/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →